By Kayla Rivas
Biotech company Moderna announced on Tuesday that its coronavirus vaccine candidate elicited immune responses in older adults from a Phase 1 study in levels comparable to those seen in younger adults.

September 30, 2020 at 06:55PM
via FOX News read more...
0 Comments